相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
Martin Korsbak Madsen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Psychedelic Psychiatry's Brave New World
David Nutt et al.
CELL (2020)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers
David Erritzoe et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia-Romeu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C. Mithoefer et al.
PSYCHOPHARMACOLOGY (2019)
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
R. L. Carhart-Harris et al.
PHARMACOLOGICAL REVIEWS (2019)
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice
Aboagyewaah Oppong-Damoah et al.
PSYCHOPHARMACOLOGY (2019)
Ketamine and depression: a narrative review
Alexandrine Corriger et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Neural correlates of the DMT experience assessed with multivariate EEG
Christopher Timmermann et al.
SCIENTIFIC REPORTS (2019)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid et al.
PSYCHOPHARMACOLOGY (2018)
Psychedelics and connectedness
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Effects of psilocybin therapy on personality structure
D. Erritzoe et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
Alan K. Davis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study
E. Dakwar et al.
NEUROPHARMACOLOGY (2018)
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Simon Reiche et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman et al.
FRONTIERS IN PHARMACOLOGY (2018)
Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca
Paulo Cesar Ribeiro Barbosa et al.
FRONTIERS IN PSYCHIATRY (2018)
Predicting Responses to Psychedelics: A Prospective Study
Eline C. H. M. Haijen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Long-term follow-up of psilocybin-facilitated smoking cessation
Matthew W. Johnson et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
Serotonin and brain function: a tale of two receptors
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Lessons to be learned from early psychedelic therapy in Denmark
David Erritzoe et al.
NORDIC JOURNAL OF PSYCHIATRY (2017)
Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation
Rainer Kraehenmann et al.
PSYCHOPHARMACOLOGY (2017)
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin L. Carhart-Harris et al.
SCIENTIFIC REPORTS (2017)
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Randall T. Brown et al.
CLINICAL PHARMACOKINETICS (2017)
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
Patrick C. Dolder et al.
CLINICAL PHARMACOKINETICS (2017)
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
Patrick C. Dolder et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
Enzo Tagliazucchi et al.
CURRENT BIOLOGY (2016)
LSD-Induced Entropic Brain Activity Predicts Subsequent Personality Change
A. V. Lebedev et al.
HUMAN BRAIN MAPPING (2016)
Default mode network coherence in treatment-resistant major depressive disorder during electroconvulsive therapy
Peter C. R. Mulders et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Psychedelics in the treatment of unipolar mood disorders: a systematic review
James J. H. Rucker et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging
Rafael G. dos Santos et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
K. P. C. Kuypers et al.
PSYCHOPHARMACOLOGY (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
Rainer Kraehenmann et al.
BIOLOGICAL PSYCHIATRY (2015)
Aberrant connectivity within the default mode network in first-episode, treatment-naive major depressive disorder
Yu Chen et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Pal-Orjan Johansen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Pharmacological Treatments for Smoking Cessation
Kate Cahill et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
Tobias Buchborn et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments of 1962
Matthew Oram
JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES (2014)
Amygdala Perfusion Is Predicted by Its Functional Connectivity with the Ventromedial Prefrontal Cortex and Negative Affect
Garth Coombs et al.
PLOS ONE (2014)
Effects of Schedule I drug laws on neuroscience research and treatment innovation
David J. Nutt et al.
NATURE REVIEWS NEUROSCIENCE (2013)
The role of oxytocin in social bonding, stress regulation and mental health: An update on the moderating effects of context and interindividual differences
Miranda Olff et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Acamprosate for Alcohol Dependence: A Sex-Specific Meta-Analysis Based on Individual Patient Data
Barbara J. Mason et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
Michael Kometer et al.
BIOLOGICAL PSYCHIATRY (2012)
Evidence of a Dissociation Pattern in Resting-State Default Mode Network Connectivity in First-Episode, Treatment-Naive Major Depression Patients
Xueling Zhu et al.
BIOLOGICAL PSYCHIATRY (2012)
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin
R. L. Carhart-Harris et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Katherine A. MacLean et al.
JOURNAL FOR THE SCIENTIFIC STUDY OF RELIGION (2012)
Therapist effects in the therapeutic alliance-outcome relationship: A restricted-maximum likelihood meta-analysis
A. C. Del Re et al.
CLINICAL PSYCHOLOGY REVIEW (2012)
Enhancement of Creative Expression and Entoptic Phenomena as After-Effects of Repeated Ayahuasca Ceremonies
Ede Frecska et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder
Charlotte H. Jorgensen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)
In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) and Hallucinogen Users
David Erritzoe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Localization of Dysfunction in Major Depressive Disorder: Prefrontal Cortex and Amygdala
Elisabeth A. Murray et al.
BIOLOGICAL PSYCHIATRY (2011)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Irving Page Lecture: 5-HT2A serotonin receptor biology: Interacting proteins, kinases and paradoxical regulation
Bryan L. Roth
NEUROPHARMACOLOGY (2011)
Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression
Lakshmi N. Yatham et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Assessment of addiction severity among ritual users of ayahuasca
Josep Maria Fabregas et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
A Nonlinear Relationship between Cerebral Serotonin Transporter and 5-HT2A Receptor Binding: An In Vivo Molecular Imaging Study in Humans
David Erritzoe et al.
JOURNAL OF NEUROSCIENCE (2010)
CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling
Ana C. Magalhaes et al.
NATURE NEUROSCIENCE (2010)
Familial Risk for Mood Disorder and the Personality Risk Factor, Neuroticism, Interact in Their Association with Frontolimbic Serotonin 2A Receptor Binding
Vibe G. Frokjaer et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Gender, personality, and serotonin-2A receptor binding in healthy subjects
Paul H. Soloff et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2010)
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
Adam L. Halberstadt et al.
PSYCHOPHARMACOLOGY (2010)
Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin
Colin Wark et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2010)
A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naive Subjects
Paulo Cesar Ribeiro Barbosa et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2009)
A self-administered Timeline Followback to measure variations in underage drinkers' alcohol intake and binge drinking
R. Lorraine Collins et al.
ADDICTIVE BEHAVIORS (2008)
Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder
Vibe G. Frokjaer et al.
BIOLOGICAL PSYCHIATRY (2008)
LSD-assisted psychotherapy in persons suffering from anxiety associated with advanced-stage life threatening diseases. A phase-II, double-blind, placebo-controlled dose-response pilot study
Torsten Passie et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
The GRID-HAMD: standardization of the Hamilton depression rating scale
Janet B. W. Williams et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
J Riba et al.
PSYCHOPHARMACOLOGY (2006)
Sources of Openness/Intellect: Cognitive and neuropsychological correlates of the fifth factor of personality
CG DeYoung et al.
JOURNAL OF PERSONALITY (2005)
Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil
PCR Barbosa et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2005)
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence:: a systematic review
B Carmen et al.
ADDICTION (2004)
Endocrine, cognitive and hippocampal/cortical 5HT1A/2A receptor changes evoked by a time-dependent sensitisation (TDS) stress model in rats
BH Harvey et al.
BRAIN RESEARCH (2003)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
J Riba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Re-evaluation of lisuride pharmacology:: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats
D Marona-Lewicka et al.
PSYCHOPHARMACOLOGY (2002)
分享论文
